Morgan Stanley’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Sell |
496,135
-2,814
| -0.6% | -$114K | ﹤0.01% | 2800 |
|
|
2025
Q1 | $21.9M | Sell |
498,949
-114,489
| -19% | -$5.01M | ﹤0.01% | 2598 |
|
|
2024
Q4 | $26.4M | Buy |
613,438
+503,697
| +459% | +$21.7M | ﹤0.01% | 2488 |
|
|
2024
Q3 | $4.87M | Sell |
109,741
-17,927
| -14% | -$795K | ﹤0.01% | 3978 |
|
|
2024
Q2 | $5.08M | Sell |
127,668
-55,367
| -30% | -$2.2M | ﹤0.01% | 3860 |
|
|
2024
Q1 | $7.89M | Sell |
183,035
-598,921
| -77% | -$25.8M | ﹤0.01% | 3530 |
|
|
2023
Q4 | $32.5M | Buy |
781,956
+463,326
| +145% | +$19.3M | ﹤0.01% | 2890 |
|
|
2023
Q3 | $12.7M | Sell |
318,630
-65,513
| -17% | -$2.6M | ﹤0.01% | 2901 |
|
|
2023
Q2 | $15.7M | Sell |
384,143
-198,929
| -34% | -$8.15M | ﹤0.01% | 2719 |
|
|
2023
Q1 | $23.9M | Sell |
583,072
-57,363
| -9% | -$2.35M | ﹤0.01% | 2223 |
|
|
2022
Q4 | $26.2M | Sell |
640,435
-138,584
| -18% | -$5.68M | ﹤0.01% | 2065 |
|
|
2022
Q3 | $31.3M | Buy |
779,019
+109,463
| +16% | +$4.4M | ﹤0.01% | 1726 |
|
|
2022
Q2 | $28.1M | Buy |
669,556
+154,928
| +30% | +$6.51M | ﹤0.01% | 1919 |
|
|
2022
Q1 | $23.3M | Sell |
514,628
-22,685
| -4% | -$1.03M | ﹤0.01% | 1951 |
|
|
2021
Q4 | $24.8M | Buy |
537,313
+134,317
| +33% | +$6.2M | ﹤0.01% | 1936 |
|
|
2021
Q3 | $19.1M | Sell |
402,996
-10,659
| -3% | -$506K | ﹤0.01% | 2135 |
|
|
2021
Q2 | $21.4M | Sell |
413,655
-66,704
| -14% | -$3.45M | ﹤0.01% | 2069 |
|
|
2021
Q1 | $24.2M | Sell |
480,359
-17,078
| -3% | -$860K | ﹤0.01% | 1740 |
|
|
2020
Q4 | $25.9M | Buy |
497,437
+83,054
| +20% | +$4.32M | ﹤0.01% | 1570 |
|
|
2020
Q3 | $18M | Sell |
414,383
-25,374
| -6% | -$1.1M | ﹤0.01% | 1560 |
|
|
2020
Q2 | $18.9M | Sell |
439,757
-373,502
| -46% | -$16.1M | ﹤0.01% | 1440 |
|
|
2020
Q1 | $29.3M | Buy |
813,259
+469,144
| +136% | +$16.9M | 0.01% | 1033 |
|
|
2019
Q4 | $15.7M | Sell |
344,115
-3,198
| -0.9% | -$146K | ﹤0.01% | 1888 |
|
|
2019
Q3 | $12.4M | Sell |
347,313
-63,409
| -15% | -$2.26M | ﹤0.01% | 1913 |
|
|
2019
Q2 | $16.4M | Sell |
410,722
-312,081
| -43% | -$12.4M | ﹤0.01% | 1653 |
|
|
2019
Q1 | $30.1M | Sell |
722,803
-126,317
| -15% | -$5.25M | 0.01% | 1142 |
|
|
2018
Q4 | $31.1M | Sell |
849,120
-29,199
| -3% | -$1.07M | 0.01% | 1102 |
|
|
2018
Q3 | $42.7M | Buy |
878,319
+295,396
| +51% | +$14.3M | 0.01% | 1060 |
|
|
2018
Q2 | $25.1M | Sell |
582,923
-234,618
| -29% | -$10.1M | 0.01% | 1437 |
|
|
2018
Q1 | $34.2M | Buy |
817,541
+250,687
| +44% | +$10.5M | 0.01% | 1197 |
|
|
2017
Q4 | $24.7M | Sell |
566,854
-74,668
| -12% | -$3.25M | 0.01% | 1487 |
|
|
2017
Q3 | $27.3M | Buy |
641,522
+23,517
| +4% | +$1M | 0.01% | 1328 |
|
|
2017
Q2 | $26.6M | Buy |
618,005
+1,327
| +0.2% | +$57.1K | 0.01% | 1298 |
|
|
2017
Q1 | $25.8M | Buy |
616,678
+294,560
| +91% | +$12.3M | 0.01% | 1355 |
|
|
2016
Q4 | $12.6M | Buy |
322,118
+43,527
| +16% | +$1.7M | ﹤0.01% | 2010 |
|
|
2016
Q3 | $12.3M | Sell |
278,591
-94,674
| -25% | -$4.18M | ﹤0.01% | 1841 |
|
|
2016
Q2 | $15.6M | Sell |
373,265
-114,495
| -23% | -$4.79M | 0.01% | 1622 |
|
|
2016
Q1 | $19.6M | Sell |
487,760
-352,346
| -42% | -$14.2M | 0.01% | 1319 |
|
|
2015
Q4 | $43M | Sell |
840,106
-22,819
| -3% | -$1.17M | 0.02% | 876 |
|
|
2015
Q3 | $40.5M | Sell |
862,925
-317,911
| -27% | -$14.9M | 0.02% | 913 |
|
|
2015
Q2 | $73.6M | Buy |
1,180,836
+57,310
| +5% | +$3.57M | 0.03% | 655 |
|
|
2015
Q1 | $69.4M | Sell |
1,123,526
-15,550
| -1% | -$960K | 0.03% | 667 |
|
|
2014
Q4 | $61.5M | Sell |
1,139,076
-22,782
| -2% | -$1.23M | 0.02% | 738 |
|
|
2014
Q3 | $61.6M | Buy |
1,161,858
+4,620
| +0.4% | +$245K | 0.02% | 727 |
|
|
2014
Q2 | $60.1M | Sell |
1,157,238
-91,456
| -7% | -$4.75M | 0.02% | 709 |
|
|
2014
Q1 | $58.4M | Buy |
1,248,694
+183,526
| +17% | +$8.59M | 0.02% | 677 |
|
|
2013
Q4 | $46.9M | Sell |
1,065,168
-4,482
| -0.4% | -$197K | 0.02% | 775 |
|
|
2013
Q3 | $41.2M | Buy |
1,069,650
+20,480
| +2% | +$788K | 0.02% | 769 |
|
|
2013
Q2 | $37M | Buy |
+1,049,170
| New | +$37M | 0.02% | 792 |
|